Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

Title
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
Authors
Keywords
-
Journal
Lancet Respiratory Medicine
Volume 2, Issue 7, Pages 539-547
Publisher
Elsevier BV
Online
2014-05-16
DOI
10.1016/s2213-2600(14)70100-6

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now